Skip to main content

Table 1 Detection rates of the GynTect assay for the sample cohort in PreservCyt (Hologic)

From: Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages

All ages

CxCa (n = 5)

CIN3 (n = 50)

CIN2 (n = 19)

CIN1 (n = 5)

NILM (n = 201)

# tested samples

5

50

19

5

201

# GynTect positive

5

30

8

1

3

# GynTect negative

0

19

10

4

196

# GynTect invalid

0

1

1

0

2

# valid samples

5

49

18

5

199

detection rate [%]

100.0%

61.2%

44.4%

20.0%

1.5%